2022.10.06
Consumption of L. lactis Strain Plasma Reduces Cold-like Symptoms and Sick Days in Vietnamese Elementary Schools
Kirin Holdings Central Research Institute, in collaboration with the National Institute of Nutrition in Vietnam (NIN), has conducted a clinical trial in which approximately 1,000 first- to third-grade students in Vietnamese elementary schools consumed beverages containing approximately 100 billion units of L. lactis strain Plasma (LC-Plasma) or control beverages not containing it for 8 weeks. Results showed that the cumulative number of days of fever, diarrhea and other cold-like symptoms and the cumulative number of days of school absences due to such symptoms were significantly fewer in the group that consumed the beverage containing LC-Plasma. This is the first clinical trial involving LC-Plasma in children overseas. Suggesting that the continuous intake of LC-Plasma can be a safe and convenient measure against infectious diseases for children, the results of this study were accepted and published in Nutrients on January 27.
In the clinical trial, some 1,000 first- to third-grade elementary school students in Ninh Binh Province, Vietnam, were either given or not given LC-Plasma for a period of 8 weeks.
In the clinical trial, some 1,000 first- to third-grade elementary school students in Ninh Binh Province, Vietnam, were either given or not given LC-Plasma for a period of 8 weeks.
There was a significant reduction in the L. lactis strain Plasma group in terms of: Cumulative school absent days (left); Cumulative fever positive days (center); and Cumulative number of days of diarrhea.
There was a significant reduction in the L. lactis strain Plasma group in terms of: Cumulative school absent days (left); Cumulative fever positive days (center); and Cumulative number of days of diarrhea.